Innate Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 797,222 | 0.986% |
Institutions | 1,848,757 | 2.29% |
Individual Insiders | 2,004,867 | 2.48% |
VC/PE Firms | 6,389,406 | 7.9% |
Public Companies | 17,303,046 | 21.4% |
General Public | 52,498,690 | 64.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,817,546 | US$24.2m | 0% | no data | |||
7,485,500 | US$18.4m | 0% | no data | |||
6,389,406 | US$15.7m | 0% | 0.09% | |||
797,222 | US$2.0m | 0% | no data | |||
739,784 | US$1.8m | 0% | no data | |||
631,088 | US$1.6m | 22.6% | no data | |||
461,757 | US$1.1m | 0% | no data | |||
320,000 | US$787.4k | 39.1% | 0.07% | |||
225,522 | US$554.9k | 381% | 0.02% | |||
210,228 | US$517.3k | 13.8% | no data | |||
209,000 | US$514.2k | 0% | 0.2% | |||
194,192 | US$477.8k | 25.5% | no data | |||
160,751 | US$395.5k | 0% | 0.01% | |||
140,000 | US$344.5k | 0% | 0.01% | |||
73,059 | US$179.8k | 0% | no data | |||
62,249 | US$153.2k | 54.3% | no data | |||
61,276 | US$150.8k | 0% | 1.5% | |||
58,500 | US$143.9k | 0% | 0.02% | |||
50,278 | US$123.7k | -12.5% | no data | |||
46,354 | US$114.1k | 3.11% | no data | |||
37,979 | US$93.4k | 80.1% | no data | |||
34,605 | US$85.2k | 0% | no data | |||
25,100 | US$61.8k | 0% | no data | |||
25,000 | US$61.5k | 0% | 0.02% | |||
22,705 | US$55.9k | -88.1% | no data |